Keywords: Gestational diabetes; Screening; OGTT; Prevalence; Population study;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Folic acid; Folate; Vitamin B12; Maternal; Paternal; Offspring; Insulin resistance; Adiposity; Peri-conceptional; DFE; Dietary folate equivalents; HOMA-IR; Homeostatic model assessment (of) insulin resistance; IR; insulin resistance; IUGR; intra uterine g
Keywords: Vasopressin; Hyperglycemia; Osmolar concentration; Drinking; ACE; angiotensin-converting enzyme; ALDO; aldosterone; AVP; arginine vasopressin; BMI; body mass index; CORT; cortisol; EUH; euhydrated trial; HOMA; homeostatic model assessment of insulin resis
Keywords: Serum immunoglobulin; Prediabetes; Cross-sectional study; IFG; impaired fasting glucose; IGT; impaired glucose tolerance; HbA1c; glycosylated hemoglobin; CVD; cardiovascular disease; NF-κB; nuclear factor-κB; Igs; immunoglobulins; T2D; type 2 diabetes;
Keywords: IMF; intermittent fasting; AL; ad libitum; HF; high-fat diet; HP; high-protein diet; AUC; area under the curve; En%; energy percent; BMD; Bone mineral density; LBM; lean body mass; FM; fat mass; DEXA; dual-energy X-ray absorptiometry; VO2; Oxygen consumpt
Keywords: Sucralose; Glucose homeostasis; OGTT; Healthy volunteers; AUC; area under the curve; EFSA; European Food Safety Authority; HbA1C; glycated hemoglobin; GIP; gastric inhibitory peptide; GLP-1; glucagon-like peptide 1; GLUT2; apical glucose transporter type
Keywords: central sleep apnea; diabetic complications; gestational diabetes; OSA; sleep apnea; type 1 diabetes; type 2 diabetes; weight loss; AHI; apnea-hypopnea index; GLP-1; glucagon-like peptide 1; HbA1c; hemoglobin A1c; HOMA; homeostatic model assessment; IVGTT
Keywords: BP; blood pressure; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; GLP-1; glucagon-like peptide-1; H. pylori; Helicobacter pylori; HbA1c; glycosylated haemoglobin; HC; hip circumference; HDL-Chol; high-density lipoprotein chol
Keywords: cystic fibrosis; diabetes; Intermediate time points; OGTT; screening test; fibrose kystique; diabète; Temps intermédiaires; HGPO; test de dépistage;
Keywords: Diabetes mellitus; Abdominal aortic aneurysm; Mortality; Glycaemic status; HbA1c; OGTT;
Keywords: TNF-α; tumor necrosis factor-α; Hs-CRP; high sensitivity C-reactive protein; MoM; multiple of the median; GDM; gestational diabetes mellitus; LGA; large for gestational age; OGTT; oral glucose tolerance test; ROC; receiver operating characteristic; DR;
Keywords: SGLT2 inhibitor; DPP4 inhibitor; Canagliflozin; Combination treatment; Glucagon-like peptide-1; aGLP-1; active GLP-1; ANOVA; Analysis of variance; AUC; Area under the curve; CMA; (2S)-2-Cyano-1-[trans-4-(morpholinocarbonyl)cyclohexylamino]acetylpyrrolidin
Keywords: Birth weight; Pregnancy; GDM; Blood glucose; OGTT;
Keywords: AUC; area under the curve; BMI; body mass index; CaSR; calcium sensing receptor; CV; coefficient of variation; DPP-IV; dipeptidyl peptidase-IV; GLP-1; glucagon-like peptide-1; GPCR; G-protein coupled receptor; HV; healthy volunteer; OGTT; oral glucose tol
Keywords: AUC; area under the curve; BB-DP; BioBreeding Diabetes-Prone; BB/OK; BioBreeding/Ottawa Kalsburg; cDM; canine diabetes mellitus; DM; diabetes mellitus; DLA; Dog Leukocyte Antigen; FPG; fasting plasma glucose; GIR; glucose infusion rate; GTT; glucose toler
Keywords: APH; antepartum haemorrhage; DIAMOND; Diabetes Clinical Management System; GDM; gestational diabetes mellitus; GP; general practitioner; LGA; large for gestational age; NICU; neonatal intensive care unit; OGTT; oral glucose tolerance test; PET; preeclamps
Keywords: Statin; Insulin secretion; Glucose uptake; Glucose homeostasis; Islet; Beta cell; Adipose tissue; Muscle; OGTT; Transmission electron microscopy; Ca2 + measurements
Keywords: 25 OHD; 25 hydroxy vitamin D; BMD; bone mineral density; BAP; bone specific alkaline phosphatase; BTM; bone turnover marker; PICP; carboxy-terminal propeptide of type I procollagen; CICP; collagen type 1C propeptide; CTX; C-terminal cross-link of collagen
Keywords: CF; Cystic fibrosis; CFRD; Cystic fibrosis related diabetes; CGM; Continuous glucose monitoring; FPG; Fasting plasma glucose; IFG; Impaired fasting glucose; IGT; Impaired glucose tolerance; OGTT; Oral glucose tolerance test; Cystic fibrosis; Hypoglycaemia
Keywords: CRP; C-reactive protein; HDL; high density lipoprotein; LDL; low density lipoprotein; PPARγ; peroxisome proliferator activated receptor-γ; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon like peptide-1; TRIB3; tribbles homolog 3; ATF-4; activating transc
Keywords: PCOS; diabetes mellitus; abnormal glucose tolerance; OGTT; family history; IR; hyperandrogenism;
Keywords: AIP2; apoptosis inhibitory protein 2; BCL2; B-cell lymphoma 2; CUS; chronic unpredictable stress; FST; forced swim test; GLP1; glucagon like peptide 1; GLUT4; glucose transporter type 4; HPA axis; hypothalamic-pituitary-adrenal axis; INSG1; insulin in
Keywords: AUC; Area under the curve; BMI; Body mass index; CGM; Continuous glucose monitoring; CRP; C-reactive protein; HbA1c; Hemoglobin A1c; HDL-C; High density lipoprotein-cholesterol; ICAM-1; Intercellular adhesion molecule 1; iHOMA2; Interactive homeostatic mo
Keywords: Diabetes; pregnancy; stillbirth; ACOG; American College of Obstetricians and Gynecologists; BMI; body mass index; CDA; Canadian Diabetes Association; DM; diabetes mellitus; FPG; fasting plasma glucose; GCT; glucose challenge screening test; GDM; gestation
Keywords: SM; sphingomyelin; SMS; sphingomyelin synthase; Cer; ceramide; CerS; ceramide synthase; S1P; sphingosine 1 phosphate; LC/ESI-MS/MS; liquid chromatography/electrospray ionization-tandem mass spectrometry; VLCFA; very long-chain fatty acid; HexCer; hexosylc
Keywords: DSP-4; Blood glucose; OGTT; Restraint stress; Spinal; Supra spinal;
Keywords: chest imaging; diabetes; global medicine; tuberculosis; DM; diabetes mellitus; DOTS; directly observed therapy, short course; EDOTS; Effects of Diabetes on Tuberculosis Severity Study; FPG; fasting plasma glucose; HbA1c; hemoglobin A1c, or glycohemoglobin
Keywords: PCOS; polycystic ovary syndrome; INSL3; insulin-like factor 3; RXFP2; relaxin/insulin-like family peptide receptor-2; GDF-9; growth differentiation factor 9; BMI; body mass index; WHR; waist to hip ratio; FBS; fasting blood glucose; OGTT; oral glucose-tol
Keywords: T2DM; Type 2 diabetes mellitus; FPG; Fasting plasma glucose; OGTT; Oral glucose tolerance test; LRÂ +; Â Positive likelihood ratios; LRÂ â; Â Negative likelihood ratios; CI; Confidence interval; ROC; Receiver operating characteristic; HSROC; Hierarchica
Keywords: Biomarker; Diabetes; Metabolomics; Glucose; Predictive modeling; ANOVA; analysis of variance; AUC; area under the receiver operating characteristic curve; BMI; body mass index; BRC; Bavarian Red Cross Blood Transfusion Center study; ELISA; enzyme-linked i
Keywords: Bacteroidetes; Firmicutes; Insulin resistance; Intestinal microbiome; Short-chain fatty acid; Sleep restriction; d2; day 2; F:B; Firmicutes:Bacteroidetes (ratio); HDL; high-density lipoprotein; HOMA-IR; homeostatic assessment model of insulin resistance;
Keywords: AUC; area under the curve; dAUC; incremental integrated area under the curve; FCH; familial combined hyperlipidemia; OGTT; oral glucose tolerance test; T2DM; type 2 diabetes mellitus; Inflammation; Integrin; Diabetic complications; Atherosclerosis;
Keywords: High-fat diet; Mouse islet; Insulin translation; AHA; l-azidohomoalanine; CHX; cycloheximide; HF; high-fat; ITT; insulin tolerance test; KRB; Krebs-Ringer buffer; MafA; musculoaponeurotic fibrosarcoma oncogene family, protein A; NC; normal chow; OGTT; o
Keywords: RPON; recurrent painless ophthalmoplegic neuropathy; VAS; visual analog scale; MRI; magnetic resonance imaging; NSAI; non-steroidal anti-inflammatory; PTZ-INR; partial thrombin time-International normalized ratio; aPTT; activated partial thrombin time
Keywords: MeHg; methyl mercury; TDI; tolerable daily intake; IFG; impaired fasting glycemia; IGT; impaired glucose tolerance; T2D; type 2 diabetes; HOMA-IR; homoeostatic model assessment for hepatic insulin resistance; OGTT; oral glucose tolerance test; ISI0,120; p
Keywords: BMI; body mass index; DM; diabetes mellitus; GCT; glucose challenge test; GDM; gestational diabetes mellitus; IUFD; intrauterine fetal death; LGA; large for gestational age; OGTT; oral glucose tolerance test; PPH; postpartum hemorrhage; T2DM; type 2 diabe
Keywords: FFA1 agonist; OGTT; Amide linkers; Ligand efficiency; Type 2 diabetes
Keywords: ANOVA; analysis of variance; BCAAs; branched-chain amino acids; BIA; bioelectrical impedance analysis; BMI; body mass index; FFAs; free fatty acids; FFM; fat free mass; HOMA-IR; homeostatic model assessment of insulin resistance; HPLC; high-performance li
Keywords: Lifestyle; Type 2 diabetes; Cholesterol metabolism; Plant sterols; Insulin sensitivity; DI30; disposition index; DPS; Diabetes Prevention Study; IGT; impaired glucose tolerance; IS; insulin sensitivity; ISI; insulin sensitivity index; OGTT; oral glucose t
Keywords: WHO; World Health Organization; HbA1c; glycated hemoglobin; GA; glycated albumin; OGTT; oral glucose tolerance test; KOPS; Kyushu and Okinawa Population Study; FPG; fasting plasma glucose; eGFR; estimated glomerular filtration rate; 2Â h-PG; 2Â hour postp
Keywords: 12(13)Ep-9-KODE; 2(13)Epoxy-9-ketooctadecadienoic acid; % en; % of energy; ALA; α-Linolenic acid; ArA; Arachidonic acid; AUC; Area under the curve; AutOx; Auto-oxidation; BHT; 2,6-Di-tert-butyl-4-methylphenol; COX; Cyclooxygenase; CYP; Cytochrome P450; D
Keywords: AIT; Aerobic interval training; AUC; Area under the curve; CAD; Coronary artery disease; FPG; Fasting plasma glucose; FPI; Fasting plasma insulin; IFG; Impaired fasting glucose; IGT; Impaired glucose tolerance; ISI; Insulin sensitivity index; HOMA; Homeos
Keywords: APL; Acquired partial lipodystrophy; CGL; Congenital generalized lipodystrophy; MPGN; Membranoproliferative glomerulonephritis; FPL; Familial partial lipodystrophy; TuLip; Turkish Lipodystrophy Study Group; WB MRI; Whole body magnetic resonance imaging; N
Keywords: Endocrine outcomes; Endoscopic endonasal surgery; Giant macroadenoma; Large macroadenoma; Pituitary macroadenoma; Skull base surgery; Visual outcomes; CSF; Cerebrospinal fluid; DI; Diabetes insipidus; GH; Growth hormone; GTR; Gross total resection; HRT; H
Keywords: GLP-1; glucagon-like peptide 1; 25OHD; 25-hydroxyvitamin D; RDA; recommended daily allowance; IGF-1; insulin-like growth factor 1; HDL; high density lipoprotein; HOMA-IR; homeostatic model assessment of insulin resistance; HbA1c; glycated hemoglobin; HFD;
Keywords: Gestational diabetes; Maternal diabetes; Childhood obesity; Epigenetics; Type 2 diabetes; ACHOIS; Australian Carbohydrate Intolerance Study in Pregnancy Women; ALSPAC; Avon Longitudinal Study of Parents and Children; BMI; Body mass index; EPOCH; Exploring
Keywords: ModEx; moderate-intensity aerobic continuous exercise; IntEx; high-intensity aerobic interval exercise; BMI; body mass index; NoEX; no exercise; VO2max; maximal oxygen uptake; GLP-1; glucagon-like peptide-1; GIP; glucose-dependent insulinotropic polypepti
Keywords: Metabolic programming; Hepatic steatosis; Oxidative stress; Lipogenesis; β-Oxidation; Stereology; Mice; BM; body mass; CAT; catalase; CPT; carnitine palmitoyl-CoA transferase; DIO; diet-induced obesity; FAS; fatty acid synthase; FFA; free fatty acids; GP
Keywords: T2D; Type 2 diabetes; CVD; Cardiovascular disease; ADA; American Diabetes Association; BP; Blood pressure; OGTT; Oral glucose tolerance test; IVGTT; Intravenous glucose tolerance test; FMD; Flow mediated dilation; EID; Endothelial independent vasodilation
Keywords: BMI; body mass index; DPP; Diabetes Prevention Programme; DPS; Finnish Diabetes Prevention Study; IDRF; India Diabetes Research Foundation; IGT; impaired glucose tolerance; IFG; impaired fasting glucose; NCD; non communicable diseases; OGTT; oral glucose